Protein Hyperactivation Could Kill Cancer Cells and Bacteria
Technology Networks had the pleasure of speaking with Walid A. Houry, professor of biochemistry at the University of Toronto, to find out about the discovery of compounds that can induce protease hyperactivation to kill cancer cells.
Septic Shock and Metastases: Finding the Culprits
A new molecule, based on the anti-diabetes drug metformin, can bind copper, found to be important in acute inflammation, sepsis and cancer dissemination, and thus holds great promise for new therapy.
Advances in Cell Therapy
In this article, we review the latest research in cell therapy development, including advances made in the lab that show promise for translation to the clinic, to improvements in developing, testing and manufacturing.
Improving Image Integrity in Scientific Papers
This article sheds light on the issue of image integrity in academic publishing and gives advice on how to reduce the risk.
Redefining Cancer-Free With ctDNA
In this article, we dive into MRD and how it promises to both address an unmet need in the care of cancer patients and ultimately help patients live longer lives with less uncertainty.
The Impact of UK Collaboration in Life Sciences
In this opinion piece, Jan Wauters discusses why collaboration in science is so important and what the Windsor Framework could mean for research in Europe.
What Are Neoantigens?
In this article, we will define what neoantigens are, explore how they arise, the different types of neoantigens and understand how neoantigen-targeting therapies work.
ChatGPT: It’s Not the End of the World as We Know It
In this op-ed article, Michael Kinch explains his optimism around ChatGPT which, in his words, centers around the possibility that we as a society might start to question "claims" and "truths" that we encounter daily.
Cutting With CRISPR: Assessing Safety as Technology Moves Into the Clinic
The Nobel Prize winning CRISPR-Cas genome editing technology is being adopted for a wide variety of research applications. In this article, we will explore what these applications are and outline the progress of CRISPR methodologies in recent years, in addition to current bottlenecks in CRISPR research and how we can look to address them.
Applications of Liquid Biopsy in Cancer and Beyond
Liquid biopsies are becoming an increasingly important tool for the early detection, prognosis and monitoring of treatment outcomes in cancer, and hold the promise of transforming the management of other diseases in the future.